Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Rapti, E., Karras S., Grammatiki M., Mousiolis A., Tsekmekidou X., Potolidis E., et al. (2016).  Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults.. Endocrinol Diabetes Metab Case Rep. 2016, 150136.
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Dedemadi G., Goumas C., et al. (2014).  The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer.. Tumour Biol. 35(6), 5993-6002.
Spachos, D., Siafis S., Bamidis P., Kouvelas D., & Papazisis G. (2020).  Combining big data search analytics and the FDA Adverse Event Reporting System database to detect a potential safety signal of mirtazapine abuse.. Health Informatics J. 26(3), 2265-2279.
Wing, A. M., Doumas M., & Welchman A. E. (2010).  Combining multisensory temporal information for movement synchronisation.. Exp Brain Res. 200(3-4), 277-82.
Dokos, C., & Tsakalidis C. (2011).  Comment and reply on: Metabolomics of amniotic fluid and preterm delivery.. J Matern Fetal Neonatal Med. 24(12), 1504; author reply 1504-5.
Sountoulides, P., & Bantis A. (2014).  Comment on "A Biochemical Evaluation on Inflammatory Markers after Ureteroscopic Lithotripsy".. Int Sch Res Notices. 2014, 919801.
Kyrgidis, A., & Triaridis S. (2009).  Comment on: Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.. Oral Oncol. 45(6), e38; author reply e39.
Apalla, Z., Lazaridou E., & Lallas A. (2020).  Comment on: Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes.. J Am Acad Dermatol.
Peris, K., Fargnoli M. C., Garbe C., Kaufmann R., Bastholt L., Seguin N. B., et al. (2020).  Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'.. Eur J Cancer. 131, 100-103.
Alexiou, G. A., Voulgaris S., Polyzoidis K., Fotopoulos A. D., Tsiouris S., & Kyritsis A. P. (2009).  Comment on "Differentiation of tumour recurrence from radiation necrosis in high-grade gliomas using (201)Tl-SPECT".. J Clin Neurosci. 16(8), 1112.
Kazakos, E. I., Dorrell N., Polyzos S. A., Deretzi G., & Kountouras J. (2017).  Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics".. World J Gastroenterol. 23(33), 6194-6196.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2012).  Comment on: Jeon et al. Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525.. Diabetes Care. 35(7), e53; author reply e54.
Kirmizis, D. A., Chatzidimitriou D. A., & Tzimagiorgis G. ch (2010).  Comment on "Non-hepatitis virus-associated mixed essential cryoglobulinemia".. Kidney Int. 78(1), 113-4; author reply 114.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease.. Expert Opin Ther Targets. 17(7), 861-2.
Tsivgoulis, G., Palaiodimou L., Katsanos A. H., Voumvourakis K., Hadjigeorgiou G. M., Heliopoulos I., et al. (2019).  Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".. CNS Drugs. 33(3), 293-295.
Cholongitas, E., Spyrou S., Georgousaki C., & Dasenaki M. (2010).  Comment on: Recurrent skin reaction attributable to darbepoetin alfa in a patient with chronic renal failure.. Ren Fail. 32(4), 528.
P White, L., Barnes R. A., Gorton R., Cruciani M., & Loeffler J. (2019).  Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.. J Antimicrob Chemother. 74(2), 532-533.
Meletis, G., Protonotariou E., Papadopoulou D., & Skoura L. (2016).  Comment on: The Carbapenemase Menace: Do Dual Mechanisms Code for More Resistance?. Infect Control Hosp Epidemiol. 37(11), 1392-1394.
Kountouras, J., Tsiaousi E., Trigonis S., Polyzos S. A., Katsinelos P., Zavos C., et al. (2016).  Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia".. Eur Rev Med Pharmacol Sci. 20(1), 3-4.
Georgakarakos, E., Ioannou C. V., Kostas T., Katsamouris A. N., & Papaharilaou Y. (2010).  Comment on "the influence of wall stress on AAA growth and biomarkers".. Eur J Vasc Endovasc Surg. 39(6), 796; author reply 797.
Paschou, S. A., Sydney G. I., Ioakim K. J., Kotsa K., & Goulis D. G. (2020).  Comment on the systematic review and meta-analysis titled "Gestational diabetes and the risk of cardiovascular disease in women".. Hormones (Athens). 19(3), 447-448.
Kountouras, J., Polyzos S. A., Doulberis M., Stergiopoulos C., & Katsinelos P. (2018).  Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease".. J Immunol. 200(9), 3027.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".. Dig Liver Dis. 45(1), 82-3.
Natsis, K., & Piagkou M. (2013).  Commentary.. J Neurosci Rural Pract. 4(4), 397-8.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Romiopoulos I., Berdeni Α., Zavos C., et al. (2021).  Commentary: are blood and saliva sources of COVID-19 spread?. Eur Rev Med Pharmacol Sci. 25(15), 4872-4874.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.